BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Vanton Research Laboratory Receives FDA's Pre-approval Inspection (PAI) Acceptance Notification


10/26/2011 12:41:19 PM

CONCORD, C.A.—VANTON RESEARCH LABORATORY, LLC (“VRL”) today announced the receipt of an acceptance letter from U.S. Food and Drug Administration (FDA) regarding its pre-approval Inspection (PAI) conducted in August 2011. The acceptance letter pertained to the FDA PAI inspection on VRL’s commercial testing capability, in particular the stability program which the company has been establishing during the past several years. FDA Inspectors found VRL’s quality system compliant with current GMP requirements and the associated equipment and infrastructure qualified for conducting commercial scale stability testing.

About Vanton

Vanton Research Laboratory, LLC is a privately owned contract research organization (CRO) specializing in development of non-conventional drug delivery systems. It also provides a comprehensive range of fully integrated Pharmaceutical Development Services including pre-formulation, formulation, analytical development, and clinical manufacturing. In addition to CRO services, Vanton also develops in-house specialty products. The company’s pipeline products include a subcutaneous depot system using its proprietary molecular caging (MC) technology to deliver Ropivacaine for managing post-operational pain, in addition to a range of chronic disease treatment products using its novel sustained released oral disintegrating tablet (ODT-SR) technology.

For more information about the company, please visit www.vantonlab.com.

CONTACT:

Vanton Research Laboratory, LLC

Ms. Julie M. Chen

Chief Operating Officer

Tel: 925-687-7814

Investor Relations:

Ms. Carol Hafizi

carolhafizi@vantonlab.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES